| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918881 | Radiotherapy and Oncology | 2012 | 7 Pages |
Abstract
Hypofractionated radiotherapy is clinically feasible and more convenient than conventional schedules for patients with localized prostate cancer. Phase 3 multicenter studies are on-going (NCT00126165).
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Jackson S.Y. Wu, Penelope M.A. Brasher, Ali El-Gayed, Nadeem Pervez, Patricia T. Tai, John Robinson, David Skarsgard, Kurian Joseph, Michael A. Sia, Robert G. Pearcey,